Keacyte

Keacyte is a commercial excellence platform developed specifically for life sciences companies, including pharmaceutical, biotechnology, and medical device organisations. The platform provides an integrated suite of tools covering compliance management, regulatory oversight, sales automation, content management, and customer engagement, with the goal of streamlining pharma commercialisation from a single unified application.

Keacyte serves over 40 customers across more than 7 countries, with a user base exceeding 60,000 individuals. The platform is designed to address the distinct requirements of life sciences companies, offering a preconfigured data model tailored to the industry alongside customisation options, and supporting regulatory compliance frameworks including UCPMP and Sunshine Act requirements. It also provides integration capabilities with industry-specific process and data applications.

Platform Suites

• Pulse Suite: Designed to translate commercial plans into action from a single platform, covering planning and execution workflows for field teams.
• Engage Suite: Focuses on faster content reviews, seamless collaboration, and consistent compliance across marketing and sales activities.
• Reg-Content Suite: Provides robust functionality and integrations for managing regulatory and promotional content delivery.
• Audit Suite: Offers a unified dashboard to measure and monitor all commercialisation efforts and field activity.

Applications and Modules

• Call Planning and Call Reporting: Supports structured planning of physician visits and records field interactions, including speech recognition for easy post-call logging.
• E-Detailing and CLM Campaigns: Enables delivery of approved promotional content to healthcare professionals through digital channels.
• Approved Email: Facilitates compliant email communication with customers.
• Events Management: Handles the planning and tracking of meetings and events.
• Expense Management: Tracks and manages field force expenses.
• PI Management: Manages prescribing information and related documentation.
• RCPA (Retail Chemist Prescription Audit): Provides visibility into prescription and sales data at the retail level.
• Expiry Optimization: Assists in managing product expiry across the supply chain.
• Incentive Management: Supports the calculation and management of field force incentives.
• Master Data Management: Centralises and manages core commercial data.
• CMS (Content Management System): Manages promotional and regulatory content.
• E-Learning: Provides training and learning resources for field teams.
• Insights and BI: Delivers business intelligence, analytics, and real-time reporting for field reps, managers, and commercial excellence teams, supporting complex computations, data blending, and dashboard visualisations.

Industry-Specific Positioning

• Keacyte is positioned as purpose-built for life sciences, in contrast to generic CRM or commercial platforms that serve multiple industries.
• The platform includes features such as compliant content management and healthcare professional (HCP) tracking that go beyond standard CRM functionality.
• Regulatory compliance support covers UCPMP and Sunshine Act requirements, addressing the specific compliance needs of pharmaceutical and life sciences companies.
• Multi-channel engagement capabilities include e-detailing, phone calls, and WhatsApp integration, enabling field teams to connect with customers across preferred channels.
• Configurable approval workflows are available for processes such as call planning and content sign-off.

Customers and Deployments

• Customers include Brilliant Biopharma Pvt. Ltd., TLG Pharma FZ, Wellesta, Apex Laboratories Private Limited, and deployments in markets including Australia.
• Reported use cases include salesforce activity monitoring, field manager oversight, real-time BI reporting, RCPA implementation, and multi-channel marketing during periods such as the COVID-19 pandemic.
• Customers have noted the platform's ease of adoption, intuitive navigation, custom reporting capabilities, and low-cost BI implementation.

Keacyte is developed by VSM and is scheduled to exhibit at India Pharma Expo 2026 in Hyderabad (April 23–25, 2026, Booth No. 114 in Hall 3), reflecting its continued presence in the Indian and broader Asia-Pacific life sciences market.